Member of the Board of Directors, Corporate Development, Partnering
Pascal Brenneisen has been active in the life science industry for over 30 years as a senior executive, board member and entrepreneur and was elected to the Board of Directors of InnoMedica in 2025.
Among other things, Pascal Brenneisen was Country President and CEO of Novartis Switzerland as well as General Manager and Regional Head at Sandoz. The serial entrepreneur and owner of Brenneisen LifeScience GmbH completed his law degree in Basel in 1990, followed by various executive training courses at Harvard and Stanford Business Schools and IMD in Lausanne.
